Medical Marijuana, Inc. Announces Q2 2018 as the Largest Sales Revenue Quarter in Company History

SECOND QUARTER 2018 HIGHLIGHTS

During the second quarter of 2018, Medical Marijuana, Inc. and its subsidiaries achieved the following milestones and significant events:

1)    HempMeds®

Medical Marijuana, Inc.'s wholly owned subsidiary HempMeds® is the portfolio's predominate consumer brand and saw massive expansion and continued growth for its line of CBD hemp oil products, including the following:

• The company received the first-ever import authorization for its THC-free product Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil product in Argentina.
• The company began distribution of its Real Scientific Hemp Oil™ (RSHO™) products in Bermuda, offering them in some of the island's largest pharmacy chains.
• The company was a gold sponsor of the three-day 2018 World Medical Cannabis Conference & Expo, a conference dedicated to serving the growing national medical cannabis market.
• HempMeds® Mexico garnered international news coverage on leading business news website Forbes, which included a quote from Raul Elizalde, President of HempMeds® Latin America.
• HempMeds® Brasil announced that Norberto Fischer, professor and world-renowned speaker, has joined as a spokesperson for the company. The company also hosted two events for doctors in Brazil to learn more about CBD and its benefits.

2)    Kannaway®

Medical Marijuana, Inc.'s wholly owned subsidiary Kannaway® is the Company's premier lifestyle marketing brand and is the fastest-growing company in the direct-selling cannabis space with an exponential growth outlook for the future. The company experienced significant milestones including the following:

• Kannaway® hosted its largest-ever U.S. national event, the Empower National Convention in Las Vegas and its largest European event in Prague.
• The company brought on several professional athletes such as Christian Okoye and Amy Van Dyken.
• The company released a THC-free CBD hemp oil for pets called Dante's Pure Hemp Oil.

SECOND QUARTER 2018 FINANCIAL RESULTS

Gross Revenue ($ in millions):
Q2 2017 – $6.1M
Q2 2018 – $14.8

Gross Profit:
Q2 2017 – $4.1
Q2 2018 – $8.6

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 858-264-6600
andrew.hard@cmwmedia.com
www.cmwmedia.com

View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-announces-q2-2018-as-the-largest-sales-revenue-quarter-in-company-history-300699999.html

SOURCE Medical Marijuana, Inc.